Andrew McIvor
Overview
Explore the profile of Andrew McIvor including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
39
Citations
753
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lewis R, Niazi-Ali S, McIvor A, Kanj S, Maertens J, Bassetti M, et al.
J Antimicrob Chemother
. 2024 Apr;
79(6):1203-1217.
PMID: 38629250
Systemic antifungal therapy is critical for reducing the mortality from many invasive and chronic fungal infections. Triazole antifungals are the most frequently prescribed antifungals but require attention to dosing and...
2.
Aljazeeri J, Sakkat A, Makhdami N, Almusally R, Morfaw F, McIvor A
Can Respir J
. 2021 Nov;
2021:7449527.
PMID: 34777651
Background: Blood eosinophils predict the response to therapy, risk of exacerbation, and readmission in COPD. This study investigates whether blood eosinophils predict pulmonary rehabilitation (PR) outcomes in COPD. Methods: We...
3.
Global Quality Statements on Reliever Use in Asthma in Adults and Children Older than 5 Years of Age
Kaplan A, Correia-de-Sousa J, McIvor A
Adv Ther
. 2021 Feb;
38(3):1382-1396.
PMID: 33586006
Introduction: Widespread misuse of short-acting beta-agonists (SABAs) may contribute to asthma-related morbidity and mortality. Recognizing this, the Global Initiative for Asthma neither recommends SABA monotherapy nor regards this formulation as...
4.
McIvor A, Kaplan A
NPJ Prim Care Respir Med
. 2020 Dec;
30(1):54.
PMID: 33277487
No abstract available.
5.
Amin S, Soliman M, McIvor A, Cave A, Cabrera C
J Allergy Clin Immunol Pract
. 2020 Apr;
8(8):2556-2564.e8.
PMID: 32244024
Despite the availability of effective asthma treatments, some patients are poorly controlled because of overreliance on short-acting β-agonists (SABAs) and underuse of inhaled corticosteroids (ICSs). To identify patient characteristics and...
6.
Amin S, Soliman M, McIvor A, Cave A, Cabrera C
Patient Prefer Adherence
. 2020 Mar;
14:541-551.
PMID: 32210541
Adherence to asthma medications is generally poor and undermines clinical outcomes. Poor adherence is characterized by underuse of inhaled corticosteroids (ICS), often accompanied by over-reliance on short-acting β-agonists for symptom...
7.
Kaplan A, Arsenault P, Aw B, Brown V, Fox G, Grossman R, et al.
Can Fam Physician
. 2019 Sep;
65(9):625-633.
PMID: 31515311
Objective: To describe the burden of pneumococcal disease and associated risk factors in the Canadian adult population, delineate available pneumococcal vaccines and associated efficacy and effectiveness data, and review current...
8.
Thanh N, Jacobs P, Suggett J, McIvor A, Kaplan A
Can Respir J
. 2019 Jun;
2019:5906984.
PMID: 31236147
[This corrects the article DOI: 10.1155/2019/9176504.].
9.
Thanh N, Jacobs P, Suggett J, McIvor A, Kaplan A
Can Respir J
. 2019 Feb;
2019:9176504.
PMID: 30774739
Background: The Aerobika® oscillating positive expiratory pressure (OPEP) device is a hand-held, drug-free medical device that has been shown to improve lung function and improve health-related quality of life in...
10.
Kaplan A, Chapman K, Anees S, Mayers I, Rochdi D, Djandji M, et al.
Int J Chron Obstruct Pulmon Dis
. 2019 Feb;
14:249-260.
PMID: 30718952
Purpose: In contrast to randomized controlled trials (RCTs), changes in maintenance pharmacotherapy in clinical practice occur without a washout period. The Prospective cohort study for the real-life effectiveness evaluation of...